急性脑梗死溶栓治疗新进展

被引:30
作者
陈聪
徐运
机构
[1] 南京大学医学院附属鼓楼医院
关键词
急性脑梗死; 缺血性; 溶栓;
D O I
暂无
中图分类号
R743.33 [脑栓塞];
学科分类号
1002 ;
摘要
<正>急性缺血性脑卒中的发病率、致残率和病死率均较高,严重影响人类健康和生活。溶栓治疗是国际公认的治疗急性缺血性脑卒中的有效方法。本文简要综述近年来溶栓治疗的主要方法及新进展。静脉溶栓静脉溶栓是静脉推注或滴注溶栓药物溶解血栓,让闭塞的血管再通,使缺血但尚未坏死的脑组织(缺血半暗带)恢复灌注,避免坏死发生,改善临床结局。静脉溶栓是目前应用最广泛的溶栓方法,也
引用
收藏
页码:65 / 68
页数:4
相关论文
共 16 条
[1]  
Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis[J] . Joanna M Wardlaw,Veronica Murray,Eivind Berge,Gregory del Zoppo,Peter Sandercock,Richard L Lindley,Geoff Cohen.The Lancet . 2012 (9834)
[2]  
Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial[J] . Jeffrey L Saver,Reza Jahan,Elad I Levy,Tudor G Jovin,Blaise Baxter,Raul G Nogueira,Wayne Clark,Ronald Budzik,Osama O Zaidat.The Lancet . 2012 (9849)
[3]  
Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial[J] . Raul G Nogueira,Helmi L Lutsep,Rishi Gupta,Tudor G Jovin,Gregory W Albers,Gary A Walker,David S Liebeskind,Wade S Smith.The Lancet . 2012 (9849)
[4]  
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial[IST-3]): a randomised controlled trial[J] . Sandercock Peter,Wardlaw Joanna M,Lindley Richard I,Dennis Martin,Cohen Geoff,Murray Gordon,Innes Karen,Venables Graham,Czlonkowska Anna,Kobayashi Adam,Ricci Stefano,Murray Veronica,Berge Eivind,Slot Karsten Bruins,Hankey Graeme J,Correia Manuel,Peeters Andre,Matz Karl,Lyrer Phillipp
[5]  
Mechanical Thrombectomy in Acute Embolic Stroke: Preliminary Results With the Revive Device[J] . Stefan Rohde,Stefan Haehnel,Christian Herweh,Mirko Pham,Sibylle Stampfl,Peter A. Ringleb,Martin Bendszus.Stroke . 2011 (10)
[6]  
Rescue, Combined, and Stand-Alone Thrombectomy in the Management of Large Vessel Occlusion Stroke Using the Solitaire Device: A Prospective 50-Patient Single-Center Study: Timing, Safety, and Efficacy[J] . Stroke . 2011 (7)
[7]  
Using Recombinant Tissue Plasminogen Activator to Treat Acute Ischemic Stroke in China: Analysis of the Results From the Chinese National Stroke Registry (CNSR)[J] . Yilong Wang,Xiaoling Liao,Xingquan Zhao,David Z. Wang,Chunxue Wang,Mai N. Nguyen-Huynh,Yong Zhou,Liping Liu,Xianwei Wang,Gaifen Liu,Hao Li,Yongjun Wang.Stroke . 2011 (6)
[8]  
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials[J] . Kennedy R Lees,Erich Bluhmki,Rüdiger von Kummer,Thomas G Brott,Danilo Toni,James C Grotta,Gregory W Albers,Markku Kaste,John R Marler,Scott A Hamilton,Barbara C Tilley,Stephen M Davis,Geoffrey A Donnan,Werner Hacke.The Lancet . 2010 (9727)
[9]  
Safety and Efficacy of Ultrasound-Enhanced Thrombolysis: A Comprehensive Review and Meta-Analysis of Randomized and Nonrandomized Studies[J] . Georgios Tsivgoulis,Jürgen Eggers,Marc Ribo,Fabienne Perren,Maher Saqqur,Marta Rubiera,Theodoros N. Sergentanis,Konstantinos Vadikolias,Vincent Larrue,Carlos A. Molina,Andrei V. Alexandrov.Stroke . 2010 (2)
[10]  
First Food and Drug Administration-Approved Prospective Trial of Primary Intracranial Stenting for Acute Stroke: SARIS (Stent-Assisted Recanalization in Acute Ischemic Stroke)[J] . Elad I. Levy,Adnan H. Siddiqui,Annemarie Crumlish,Kenneth V. Snyder,Erik F. Hauck,David J. Fiorella,L Nelson Hopkins,J Mocco.Stroke . 2009 (11)